Accéder au contenu
Merck

Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor.

Journal of medicinal chemistry (2013-10-01)
Tracey Huynh, Celine Valant, Ian T Crosby, Patrick M Sexton, Arthur Christopoulos, Ben Capuano
RÉSUMÉ

The M4 mAChR is implicated in several CNS disorders and possesses an allosteric binding site for which ligands modulating the affinity and/or efficacy of ACh may be exploited for selective receptor targeting. We report the synthesis of a focused library of putative M4 PAMs derived from VU0152100 and VU10005. These compounds investigate the pharmacological effects of previously identified methoxy and fluoro substituents, providing useful estimates of affinity (KB), cooperativity (αβ), and direct agonist properties (τB).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Chlorure d′acétylcholine, ≥99% (TLC)
Sigma-Aldrich
Chlorure d′acétylcholine, suitable for cell culture
Sigma-Aldrich
Acetylcholine iodide, ≥97%
Sigma-Aldrich
Chlorure d′acétylcholine, pkg of 150 mg (per vial)
Sigma-Aldrich
Acetylcholine bromide, ≥99%
Sigma-Aldrich
Chlorure d′acétylcholine, ≥99% (TLC), free-flowing, Redi-Dri